 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
David L. Graham, General Manager Company co-founder with over 25 years in medical products industry marketing, business development and sales management. Began career at Baxter Hyland Division and was integral to launch of GAMMAGARD, IGIV. Was Director of Marketing and Corporate Development at ZymoGenetics and part of management team that secured its sale to Novo Industies. Became first Marketing Director at CellPro and helped launch the CEPRATE CD34 Selection System for lab and clinical use. Has been owner-manager of The Graham Sjostrand Group since 1995 assisting numerous healthcare clients with marketing research, new product development, business & strategic planning and business development. Has started three other medical products companies. Education: A.B Dartmouth College, MBA - Darden School at UVa. Mark E. Sjostrand, Assistant General Manager Over 35 years experience in health care and medical products management. Employed at Baxter for over twenty years in numerous QA/QC, marketing and business development positions. Helped lead pioneering efforts in blood and stem cell collection technologies. Co-founded The Graham Sjostrand Group in 1995 and has had numerous American and Japanese clients. Mark has also been involved in numerous entreprenurial ventures including BIS Laboratories and Proteogenix. Katherine A. Louie, PhD, Chief Technical Officer Prior to joining Anergix she was a Senior Researcher at the University of Southern California, Keck School of Medicine where her research focused on developing therapeutic strategies in animal models of autoimmunity. Dr. Louie received her bachelor’s degree in biophysics from the University of California, Berkeley, and her doctorate in immunology and microbiology from the University of Southern California.
|
|
